Analyst
UBS
Equibles does not estimate personal net worth.
Ash Varma is recorded as Analyst at UBS. Ash Varma has spoken on 2 earnings calls across 2 companies, most recently for Neurocrine Biosciences Inc on July 30, 2026. Those appearances were for Neurocrine Biosciences Inc (NBIX) and UNITED THERAPEUTICS Corp (UTHR). The companies whose calls Ash Varma spoke on are classified in the Healthcare sector.
“So maybe just on the perspective of Cranesity, I wanted to get your thoughts on the competitive dynamic here. So for two minutes, it's what they've acquired. they did note that there were seven LFT elevation cases versus the prior disclosure by Krenetics, which was two cases.”
“So just on Teton 1 data coming up, I wanted to understand your level of confidence here in a positive study for IPF. I know you're very confident ahead of the Teton 2 study, but just in terms of how you're thinking about for this second study, would love to get your thoughts.”
UBS
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
